Variant report
Variant | nsv1005759 |
---|---|
Chromosome Location | chr2:53000765-53033534 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541807946 | chr2:53003620-53003621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149376179 | chr2:53003644-53003645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72806386 | chr2:53003676-53003677 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs551009528 | chr2:53003704-53003705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144753491 | chr2:53003726-53003727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533534431 | chr2:53003732-53003733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1971201 | chr2:53003740-53003741 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs71406694 | chr2:53003743-53003744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567152816 | chr2:53003744-53003745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3086470 | chr2:53003762-53003763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs70941301 | chr2:53003769-53003770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376128036 | chr2:53003802-53003803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139497789 | chr2:53003836-53003837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547871862 | chr2:53003839-53003840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568001414 | chr2:53003840-53003841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527844345 | chr2:53003855-53003856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7577236 | chr2:53003884-53003885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs556983923 | chr2:53003904-53003905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576650509 | chr2:53003914-53003915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539226026 | chr2:53003937-53003938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2599284 | chr2:53003988-53003989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs572793671 | chr2:53004053-53004054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542257481 | chr2:53004058-53004059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561944460 | chr2:53004070-53004071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2599285 | chr2:53004112-53004113 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs547226624 | chr2:53004140-53004141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544398058 | chr2:53004152-53004153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2603391 | chr2:53004197-53004198 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs536398974 | chr2:53004204-53004205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533599766 | chr2:53004285-53004286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556132011 | chr2:53004296-53004297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189253994 | chr2:53004341-53004342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529614860 | chr2:53004360-53004361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78192841 | chr2:53004404-53004405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374396428 | chr2:53004409-53004410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376010699 | chr2:53004416-53004417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs72806390 | chr2:53004443-53004444 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537023050 | chr2:53004448-53004449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144216644 | chr2:53004457-53004458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192655209 | chr2:53004487-53004488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539290815 | chr2:53004510-53004511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184327814 | chr2:53004529-53004530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572656827 | chr2:53004537-53004538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146143947 | chr2:53004538-53004539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4671948 | chr2:53004560-53004561 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs558959265 | chr2:53004603-53004604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140190567 | chr2:53004702-53004703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544576667 | chr2:53004726-53004727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188958408 | chr2:53004740-53004741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572023528 | chr2:53004777-53004778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53003600-53004200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:53003800-53004200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr2:53004200-53006400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr2:53021800-53022200 | Enhancers | Adipose Nuclei | Adipose |
5 | chr2:53024200-53025200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr2:53025200-53029200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr2:53027800-53049000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr2:53029200-53029400 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
9 | chr2:53029200-53029800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr2:53029800-53033200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr2:53031200-53031800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr2:53031400-53031800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr2:53033200-53034400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |